Annie Muske

Accomplishments include more than 5 years as a pharmacist working to improve treatments, medical decisions, and fine-tune medication interventions as part of practice team. Decisive leader with excellent planning and problem-solving abilities, as well as experience in both adult and neonatal clinical environments.

Advanced Cardiac Life Support, Jan 2022 – Present

American Heart Association, exp. Jan 31, 2024

Registered Pharmacist # 125242, Minnesota Board of Pharmacy, Jul 2021 – Present

Immunization Certification Mar 2017 – Present

American Pharmacists Association (APhA) Basic Life Support for Healthcare Providers American Heart Association, exp. April 2025

Comprehensive Motivational Interviewing for Health Care Professionals Certification, Oct 2019, Purdue University

Schurr J, Muske A, Stevens C, Culbreth S, Sylvester K, Connors J. Derivation and Validation of Age and Body Mass Index Adjusted Weight-based Unfractionated Heparin Dosing. Clinical and Applied Thrombosis/Hemostasis Volume 25: 1-5; DOI: 10.1177/1076029619833480

Pevnick J, Keller M, Kennelty K, Nuckols T, Ko E, Amer K, Anderson L, Armbruster C, Conti N, Fanikos J, Guan J, Knight E, Leang D, Llamas-Sandoval R, Matta L, Moriarty D, Murray L, Muske A, Phung E, Rosen O, Rosen S, Salandanan A, Shane R, Schnipper J. The Pharmacist Discharge Care (PHARM-DC) Study: “A Multicenter RCT of Pharmacist-Directed Transitional Care to Reduce Post-Hospitalization Utilization.” Contemporary Clinical Trials Volume 106; DOI: 10.1016/j.cct.2021.106419

Murry, L.T., Keller, M.S., Pevnick, J.M. et al. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework. BMC Health Serv Res 22, 186 (2022). https://doi.org/10.1186/s12913-022-07583-5   

Muske A. Acute Parotitis: Patient Case Presentation. M Health Fairview UMMC West Bank, Minneapolis, MN. June 2022. 

Muske A. Overview of Pain Medication and Management. Presented to second year nursing students. St. Catherine’s University, Saint Paul, MN. April 2022. 

Muske A. Opioid Induced Constipation. M Health Fairview UMMC East Bank, Minneapolis, MN. April 2022.

Muske A. Digoxin Toxicity. M Health Fairview UMMC East Bank, Minneapolis, MN. April 2022.

Muske A. Systemic Mastocytosis. M Health Fairview UMMC East Bank, Minneapolis, MN. March 2022.

Muske A. Drug Interactions in Psychiatric Medications. M Health Fairview UMMC West Bank, Minneapolis, MN. January 2022. 

Muske A. The Clot Thickens: Coagulation Considerations in COVID-19 Patients. M Health Fairview Pharmacy Grand Rounds, Minneapolis, MN. November 2021. 

Muske A. Ketorolac 15mg versus 30mg for Analgesia: More is Not Always Better. M Health Fairview UMMC East Bank, Minneapolis, MN. October 2021. 

Muske A. Moore A. Formulary Management: Potassium Binders Formulary Evaluation. Presented to Pharmacy and Therapeutics Committee with successful addition of agent to formulary. M Health Fairview UMMC, Minneapolis, MN. September 2021.

Muske A. Paradoxical Reaction of IV Midazolam in Neonates. M Health Fairview UMMC West Bank, Minneapolis, MN. August 2021. 

Minnesota Society of Health-System Pharmacists, Jun 2021 – Present

American Society of Health System Pharmacists, Sep 2015 – Present

Massachusetts Society of Health-System Pharmacists, Aug 2018 – Dec 2021

Northeastern University Society of Health-System Pharmacists, Sep 2016 – May 2018

Northeastern University Alpine Ski Racing Team – Executive Board, Coach, Oct 2013 – Apr 2017

Kappa Kappa Gamma – Academic and Risk Management Boards, Sep 2014 – Apr 2017